Efficacy and safety of alogliptin in patients with type 2 diabetes mellitus: A multicentre randomized double-blind placebo-controlled Phase 3 study in mainland China, Taiwan, and Hong Kong.

Saved in:
Bibliographic Details
Title: Efficacy and safety of alogliptin in patients with type 2 diabetes mellitus: A multicentre randomized double-blind placebo-controlled Phase 3 study in mainland China, Taiwan, and Hong Kong.
Authors: Pan, Changyu1 panchy301@126.com, Han, Ping2, Ji, Qiuhe3, Li, Chengjiang4, Lu, Juming1, Yang, Jinkui5, Li, Wenhui6, Zeng, Jiaoe7, Hsieh, An ‐ Tsz8, Chan, Juliana9
Source: Journal of Diabetes. Apr2017, Vol. 9 Issue 4, p386-395. 1p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first